B02BX04|Romiplostim|BH055|NPLATE|powder and solvent for sol. for inj.|250|mcg|1|250|Amgen Europe B.V., Холандия|1224.18|1|4|0|C|| B02BX05|Eltrombopag|BH085|REVOLADE|film-coated tablet|25|mg|28|700|GlaxoSmithKline Traiding Services Ltd.|1934.05|4|0|0|C|3| B02BX05|Eltrombopag|BH086|REVOLADE|film-coated tabl.|50|mg|28|1400|GlaxoSmithKline Traiding Services Ltd.|3868.1|4|0|0|C|3| B03XA01|Erythropoietin /Epoetin zeta/|BH056|Retacrit|solution for injection, pre-filled syringe|10000|IU|6|60000|Hospira UK Ltd|527.9|2|1|0|C|| B03XA01|Erythropoietin|BH048|EPREX|sol.inj.|10000|IU|6|60000|Johnson and Johnson D. O. O., Slovenia|527.9|2|1|0|C|| B03XA01|Erythropoietin/Epoetin beta/|BH049|NEORECORMON|solution for injection, pre-filled syringe|10000|IU|6|60000|Roche Registration Limited,United Kingdom|527.9|2|1|0|C|| B03XA01|Epoetin alfa|BH050|Binocrit|sol.inj. in pre-filled syr.|10000 IU/1 ml|IU|6|60000|Sandoz GmbH, Austria|527.9|2|1|0|C|| B03XA02|darbepoetin alfa|BH057|Aranesp|solution for injection prefilled syringe with needle guard|300|mcg/0,6 ml|1|300|Amgen Europe B.V., Netherlands|882.68|3|1|0|C|| B03XA02|darbepoetin alfa|BH058|Aranesp|Solution for injection pre-filled syringe with needle guard|150|mcg/0,3 ml|1|150|Amgen Europe B.V., Netherlands|441.27|3|1|0|C|| B03XA03|Methoxy polyethylene glycol-epoetin beta|BH081|MIRCERA|solution for injection, pre-filled syringe|150|mcg/ 0,3ml|1|150|Roche Registration Ltd, UK|496.48|3|0|0|C|| B03XA03|Methoxy polyethylene glycol-epoetin beta|BH082|MIRCERA|solution for injection, pre-filled syringe|200|mcg/ 0,3ml|1|200|Roche Registration Ltd, UK|661.98|3|0|0|C|| H01AB01|Thyrotropin alfa|HH017|Thyrogen|powd. for sol. for inj.|0.9mg/ml-1.2ml|mg|2|2.16|Genzyme Europe B.V. The Netherlands|1445.41|1|4|0|C|4| H01CB02|Octreotide|HH008|Sandostatin LAR|powder for inf.|30|mg|1|30|Novartis Pharma GmbH, Germany|2093.74|2|1|0|C|| H01CB02|Octreotide|HH007|Sandostatin LAR|powder for inf.|20|mg|1|20|Novartis Pharma GmbH, Germany|1395.83|2|1|0|C|| H02AB02|Dexamethasone|HH006|Dexamethasone KRKA|sol. inj.|4|mg|25|100|KRKA d.d, Slovenia|9.9|1|0|0|C|2| H02AB02|Dexamethasone|HH004|Dexamethasone Sopharma|sol. inj.|40|mg|10|400|Софарма АД, Илиенско шосе 16, 1220 София, България|39.6|1|0|0|C|2| H02AB02|Dexamethasone|HH005|Dexamethasone Sopharma|sol. inj.|4|mg|10|40|Софарма АД|3.96|1|0|0|C|2| H02AB02|Dexamethasone|HH003|Dexamethasone Sopharma|sol. inj.|8|mg|10|80|Софарма АД, Илиенско шосе 16, 1220 София, България|7.92|1|0|0|C|2| J06BA02|Immunoglobulin Human Normal|JH001|OCTAGAM 10%|solution for infusion|100 mg/ml - 20 ml|mg|1|2000|Octapharma (IP) Ltd, Великобритания;|192.14|1|4|0|C|1| J06BA02|Normal Human Immunoglobulin (IVI g)|JH002|Privigen|solution for infusion|100 mg/ml - 25 ml|mg|1|2500|CSL Behring GmbH, Гемания|240.18|1|4|0|C|1| J06BA02|Immunoglobulin Human Normal|JH003|OCTAGAM 10%|solution for infusion|100 mg/ml - 50 ml|mg|1|5000|Octapharma (IP) Ltd, Великобритания;|480.35|1|4|0|C|1| J06BA02|Normal Human Immunoglobulin (IVI g)|JH004|Privigen|solution for infusion|100 mg/ml - 50 ml|mg|1|5000|CSL Behring GmbH, Гемания|480.35|1|4|0|C|1| J06BA02|Immunoglobulin Human Normal|JH005|OCTAGAM 10%|solution for infusion|100 mg/ml - 100 ml|mg|1|10000|Octapharma (IP) Ltd, Великобритания;|960.7|1|4|0|C|1| J06BA02|Human normal immunoglobulin (ІVІ g)|JH011|Intratect|solution for infusion|50g/l - 200 ml|mg|1|10000|Biotest Pharma GmbH, Германия|960.7|1|4|0|C|1| J06BA02|Immunoglobulin Human Normal|JH007|OCTAGAM 10%|solution for infusion|100 mg/ml - 200 ml|mg|1|20000|Octapharma (IP) Ltd, Великобритания;|1921.4|1|4|0|C|1| J06BA02|Human normal immunoglobulin (ІVІ g)|JH008|Intratect|solution for infusion|50g/l - 20 ml|mg|1|1000|Biotest Pharma GmbH, Германия|96.07|1|4|0|C|1| J06BA02|Human normal immunoglobulin (ІVІ g)|JH009|Intratect|solution for infusion|50g/l - 50 ml|mg|1|2500|Biotest Pharma GmbH, Германия|240.18|1|4|0|C|1| J06BA02|Human normal immunoglobulin (ІVІ g)|JH010|Intratect|solution for infusion|50g/l - 100 ml|mg|1|5000|Biotest Pharma GmbH, Германия|480.35|1|4|0|C|1| J06BA02|Normal Human Immunoglobulin (IVI g)|JH006|Privigen|solution for infusion|100 mg/ml - 100 ml|mg|1|10000|CSL Behring GmbH, Гемания|960.7|1|4|0|C|1| L01AA01|Cyclophosphamide|LH079|ENDOXAN|power for solution for injection|200|mg|10|2000|Baxter Oncology GmbH, Germany|51.74|1|4|0|C|| L01AA06|Ifosfamide|LH082|HOLOXAN|power for sol. for inj.|1000|mg|1|1000|Baxter Oncology GmbH, Germany|47.21|1|4|0|C|| L01AA09|Bendamustine hydrochloride|LH272|Levact 2,5 mg/ml|powder for concentrate for solution for infusion|100 mg|mg|5|500|Astellas Pharma GmbH, Germany|2574.92|1|4|0|C|| L01AA09|Bendamustine hydrochloride|LH347|Levact 2,5 mg/ml|powder for concentrate for solution for infusion|25 mg|mg|5|125|Astellas Pharma GmbH, Germany|643.73|1|4|0|C|| L01AA09|Bendamustine hydrochloride|LH345|Lynetoril|powder for concentrate for sol. for inf.|100|mg|5|500|Chiesi Pharmaceuticals GmbH, Austria|2574.92|1|4|0|C|| L01AA09|Bendamustine hydrochloride|LH346|Lynetoril|powder for concentrate for sol. for inf.|25|mg|5|125|Chiesi Pharmaceuticals GmbH, Austria|643.73|1|4|0|C|| L01AX03|Temozolomide|LH235|Temozolоmide Sandoz|hard caps.|100|mg|20|2000|Sandoz Pharmaceuticals GmbH, Germany|690.56|4|0|0|C|3| L01AX03|Temozolomide|LH307|Brastoryn|hard capsules (in bottles)|100|mg|5|500|Ромастру Трейдинг ЕООД, България|172.64|4|0|0|C|3| L01AX03|Temozolomide|LH256|Temodal|hard caps. in individual sachet|100|mg|5|500|Merck Sharp & Dohme Ltd, UK|172.64|4|0|0|C|3| L01AX03|Temozolomide|LH091|Temozolomide Teva|caps. hard|100|mg|5|500|Teva Pharma B.V, The Netherland|172.64|4|0|0|C|3| L01AX03|Temozolomide|LH273|Blastomat|hard caps.|100|mg|5|500|Alvogen IPCo.SARL Люксембург|172.64|4|0|0|C|3| L01AX03|Temozolomide|LH280|Nogron|hard caps.|100|mg|5|500|EGIS Pharmaceuticals PLC, Унгария|172.64|4|0|0|C|3| L01AX03|Temozolomide|LH308|Brastoryn|hard capsules (in bottles)|20|mg|5|100|Ромастру Трейдинг ЕООД, България|34.53|4|0|0|C|3| L01AX04|Dacarbazine|LH103|DACARBAZIN TEVA|powder for solution for injection|200|mg|10|2000|Тева Фармасютикълс България ЕООД|161.17|1|4|0|C|| L01BA04|Pemetrexed|LH105|ALIMTA|powd. for conc. for infusion|500|mg|1|500|Eli Lilly Netherland B.V.|2126.59|1|4|0|C|| L01BB04|Cladribine|LH108|Litak|solution for injection|10|mg|1|10|Lipomed GmbH, Germany|618.67|1|4|0|C|| L01BB05|Fludarabine phosphate|LH287|Fludarabine Actavis|concentrate for solution for injection or infusion|25 mg/ml-2 ml|mg|1|50|Actavis Group PTC ehf.,Исландия|55.36|1|4|0|C|| L01BB05|Fludarabine phosphate|LH213|Fludara oral|film. coat. tabl.|10|mg|20|200|Bayer Schering Pharma AG, Germany|561.97|4|0|0|C|3| L01BB05|Fludarabine phosphate|LH111|Fludara|powder for sol. for inj./inf.|50|mg|5|250|Bayer Schering Pharma AG, Germany|276.79|1|4|0|C|| L01BB05|Fludarabine phosphate|LH219|Fludarabine Actavis|powder for sol. for inj./inf.|50|mg|1|50|Actavis Group PTC enf., Iceland|55.36|1|4|0|C|| L01BB06|Clofarabine|LH117|EVOLTRA|concentrate for solution for infusion|1 mg/ml - 20 ml|mg|1|20|Genzyme Europe BV, Холандия|3196.28|1|4|0|C|| L01BB07|Nelarabine|LH119|Atriance|sol. for inf.|250|mg|6|1500|Glaxo Group Ltd, UK|3798.22|1|4|0|C|| L01BC01|Liposomal Cytarabine|LH121|DepoCyte|suspention for injection|50|mg|1|50|Pacira Ltd, MG House, Rumbolds Hill, Midhurst, West Sussex, GU29 9BY, England|3587.48|1|4|0|C|| L01BC01|Cytarabine|LH005|ALEXAN|solution for injection|50 mg/ ml - 20 ml|mg|1|1000|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|39.05|1|4|0|C|| L01BC01|Cytarabine|LH122|ALEXAN|solution for injection|50 mg/ml - 10 ml|mg|1|500|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|19.53|1|4|0|C|| L01BC01|Cytarabine|LH288|Cytarabine Accord|solution for injection or infusion|100 mg/ ml - 10 ml|mg|1|1000|Accord Healthcare Limited,UK|31.92|1|4|0|C|| L01BC02|5-Fluorouracil|LH283|5-FLUOROURACIL "EBEWE"|concentrate for solution for infusion|50 mg/ml - 10 ml|mg|10|5000|Ebewe Pharma Ges.m.b.H , Австрия|25.1|1|4|0|C|| L01BC02|Fluorouracil|LH309|Fluorouracil Accord|solution for injection or infusion|50 mg/ml - 20 ml|mg|1|1000|Accord Healthcare Limited, UK|5.02|1|4|0|C|| L01BC05|Gemcitabine|LH050|GEMCIT|powder for solution for infusion|38 mg/ml, 1000 mg/vial, 50 ml|mg|1|1000|Фрезениус Каби България ЕООД|23.97|1|4|0|C|| L01BC05|Gemcitabine|LH039|GITRABIN|powder for solution for infusion|38 mg/ml - 1 g/vial - 50 ml|mg|1|1000|Actavis Group PTC ehf., Исландия|23.97|1|4|0|C|| L01BC05|Gemcitabine|LH036|GITRABIN|powder for solution for infusion|38 mg/ml - 200 mg/vial - 10 ml|mg|1|200|Actavis Group PTC ehf., Исландия|4.79|1|4|0|C|| L01BC05|Gemcitabine|LH221|Gemcitabine Tchaikapharma|concentrate for solution for infusion|1000 mg|mg|1|1000|Чайкафарма Висококачествените Лекарства АД, гр. София|23.85|1|4|0|C|| L01BC05|Gemcitabine|LH220|Gemcitabine Tchaikapharma|powder for solution for infusion|200 mg|mg|1|200|Чайкафарма Висококачествените Лекарства АД, гр. София|4.77|1|4|0|C|| L01BC05|Gemcitabine|LH215|Gemcitabine Hospira|concentrate for solution for infusion|38 mg/ml (200mg/5,3 ml)|mg|1|200|Hospira UK Ltd, Обединеното кралство|4.79|1|4|0|C|| L01BC05|Gemcitabine|LH216|Gemcitabine Hospira|concentrate for solution for infusion|38 mg/ml (1g/26.3 ml)|mg|1|1000|Hospira UK Ltd, Обединеното кралство|23.97|1|4|0|C|| L01BC05|Gemcitabine|LH217|Gemcitabine Hospira|concentrate for solution for infusion|38 mg/ml (2g/52.6 ml)|mg|1|2000|Hospira UK Ltd, Обединеното кралство|47.94|1|4|0|C|| L01BC05|Gemcitabine|LH257|Gembin|concentrate for solution for infusion|40 mg/ml - 5 ml|mg|1|200|Actavis Group PTC enf., Iceland|4.79|1|4|0|C|| L01BC05|Gemcitabine|LH258|Gembin|concentrate for solution for infusion|40 mg/ml - 25 ml|mg|1|1000|Actavis Group PTC enf., Iceland|23.97|1|4|0|C|| L01BC05|Gemcitabine|LH259|GEMCITABINE ACCORD|concentrate for solution for infusion|100 mg/ml-20 ml|mg|1|2000|Accord Healtcare Limited, UKLH|47.94|1|4|0|C|| L01BC05|Gemcitabine|LH260|GEMCITABINE ACCORD|concentrate for solution for infusion|100 mg/ml-10 ml|mg|1|1000|Accord Healtcare Limited, UK|23.97|1|4|0|C|| L01BC05|Gemcitabine|LH279|GEMCIT|powder for solution for infusion|38 mg/ml 2 000 mg, 100 ml|mg|1|2000|Фрезениус Каби България ЕООД|47.94|1|4|0|C|| L01BC05|Gemcitabine|LH214|GEMCIT|powder for solution for infusion|38 mg/ml, 200 mg/vial, 10 ml|mg|1|200|Фрезениус Каби България ЕООД|7.59|1|4|0|C|| L01BC06|Capecitabine|LH300|Xalvobin|film-coated tabl.|500|mg|120|60000|Alvogen IPCo S.ar.l, Люксембург|86.93|4|0|0|C|3| L01BC06|Capecitabine|LH299|Coloxet|film-coated tabl.|500|mg|120|60000|Egis Pharmaceuticals PLC, Унгария|86.93|4|0|0|C|3| L01BC06|Capecitabine|LH298|Coloxet|film-coated tabl.|150|mg|60|9000|Egis Pharmaceuticals PLC, Унгария|13.04|4|0|0|C|3| L01BC06|Capecitabine|LH297|Capecitabine Actavis|film-coated tablets|500|mg|120|60000|Actavis Group PTC, Iceland|86.93|4|0|0|C|3| L01BC06|Capecitabine|LH296|Capecitabine Actavis|film-coated tabl.|150|mg|60|9000|Actavis Group PTC, Iceland|13.04|4|0|0|C|3| L01BC06|Capecitabine|LH295|Capecitabine Teva|film-coated tablets|500|mg|120|60000|Teva Pharma B.V. The Netherlands|86.93|4|0|0|C|3| L01BC06|Capecitabine|LH294|Capecitabine Zentiva|film-coated tabl.|500|mg|120|60000|Zentiva k.s.,Чешка република|86.93|4|0|0|C|3| L01BC06|Capecitabine|LH293|Capecitabine Zentiva|film-coated tabl.|150|mg|60|9000|Zentiva k.s.,Чешка република|13.04|4|0|0|C|3| L01BC06|Capecitabine|LH292|Capecitabine Sandoz|film-coated tablets|500|mg|120|60000|Sandoz d.d.,Словения|86.93|4|0|0|C|3| L01BC06|Capecitabine|LH291|Capecitabine Accord|film-coated tabl.|500|mg|120|60000|Accord Healthcare Limited, UK|86.93|4|0|0|C|3| L01BC06|Capecitabine|LH290|Capecitabine Accord|film-coated tabl.|300|mg|60|18000|Accord Healthcare Limited, UK|26.08|4|0|0|C|3| L01BC06|Capecitabine|LH289|Capecitabine Accord|film-coated tabl.|150|mg|60|9000|Accord Healthcare Limited, UK|13.04|4|0|0|C|3| L01BC06|Capecitabine|LH055|Xeloda|film-coated tabl.|500|mg|120|60000|Roche Registration Limited.UK|86.93|4|0|0|C|3| L01BC06|Capecitabine|LH054|Xeloda|film-coated tabl.|150|mg|60|9000|Roche Registration Limited, UK|13.04|4|0|0|C|3| L01BC06|Capecitabine|LH330|Capeda|film-coat. tabl.|500|mg|120|60000|“Чайкафарма Висококачествените Лекарства” АД|86.06|4|0|0|C|3| L01BC06|Capecitabine|LH329|Ecansya|film-coat. tabl.|150|mg|60|9000|KRKA, d.d.|13.04|4|0|0|C|3| L01BC06|Capecitabine|LH328|Ecansya|film-coat. tabl.|500|mg|30|15000|KRKA, d.d.|21.73|4|0|0|C|3| L01BC06|Capecitabine|LH326|Ecansya|film-coat. tabl.|500|mg|120|60000|KRKA, d.d.|86.93|4|0|0|C|3| L01BC06|Capecitabine|LH327|Ecansya|film-coat. tabl.|150|mg|30|4500|KRKA, d.d.|6.52|4|0|0|C|3| L01BC53|tegafur/gimeracil/oteracil|LH302|Teysuno|hard caps.|20 mg/5,8 mg/15,8 mg|mg|84|3494.4|Nordic Group BV, ,Холандия|676.6|4|0|0|C|3| L01BC53|tegafur/gimeracil/oteracil|LH301|Teysuno|hard caps.|15 mg/4,35 mg/11,8 mg|mg|126|3924.9|Nordic Group BV, ,Холандия|783.8|4|0|0|C|3| L01CA01|Vinblastine|LH057|Cytoblastin|solution for injection|10|mg|1|10|Cipla (UK) Ltd, UK|19.55|1|4|0|C|| L01CA02|Vincristine|LH066|Cytocristin|solution for injection|1 mg/ml - 1 ml|mg|1|1|Cipla (UK) Ltd, UK|9.96|1|4|0|C|| L01CA04|Vinorelbine|LH072|NAVELBINE|conc. for sol. for inf.|10 mg/ml - 5 ml|mg|10|500|Perre Fabre Medicament, France|62.39|1|4|0|C|| L01CA04|Vinorelbine|LH070|NAVELBINE|conc. for sol. for inf.|10 mg/ml - 1 ml|mg|10|100|Perre Fabre Medicament, France|124.78|1|4|0|C|| L01CA04|Vinorelbine|LH078|"VINORELBIN ""EBEWE"" "|concentrate for solution for infusion|10 mg/ml - 5 ml|mg|1|50|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|62.39|1|4|0|C|| L01CA04|Vinorelbine|LH073|Vinorelbin Actavis|concentrate for solution for infusion|50|mg|1|50|Актавис ЕАД, България|62.39|1|4|0|C|| L01CB01|Etoposide|LH001|"ETOPOSIDE ""EBEWE"""|concentrate for solution for infusion|20 mg/ml - 10 ml|mg|1|200|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|14.56|1|4|0|C|| L01CB01|Etoposide|LH083|Etosid|solution for infusion|100|mg|1|100|Cipla (UK) Ltd, UK|7.28|1|4|0|C|| L01CB01|Etoposide|LH098|"ETOPOSIDE ""EBEWE"""|concentrate for solution for infusion|20 mg/ml - 5 ml|mg|1|100|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|7.28|1|4|0|C|| L01CB01|Etoposide|LH092|Etoposide Actavis|concentrate for solution for infusion|20 mg/ml - 5 ml|mg|1|100|Actavis Group PTC , Iceland|7.28|1|4|0|C|| L01CB01|Etoposide|LH096|"ETOPOSIDE ""EBEWE"""|concentrate for solution for infusion|20 mg/ml - 2,5 ml|mg|1|50|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|3.64|1|4|0|C|| L01CD01|Paclitaxel|LH043|PACLITAXEL KABI|concentrate for solution for infusion|6 mg/ml - 50 ml|mg|1|300|Фрезениус Каби България ЕООД|66.05|1|4|0|C|| L01CD01|Paclitaxel|LH046|Paclitaxel Accord|concentrate for solution for infusion|6 mg/ml - 50 ml|mg|1|300|Accord Healthcare Limited, UK|66.05|1|4|0|C|| L01CD01|Paclitaxel|LH317|Paclitaxel Accord|concentrate for sol. for inf.|6mg/ml - 16,7 ml|mg|1|100.2|Accord Healthcare Ltd, UK|22.02|1|4|0|C|| L01CD01|Paclitaxel|LH037|PACLITAXEL KABI|concentrate for solution for infusion|6 mg/ml - 16,7 ml|mg|1|100.2|Фрезениус Каби България ЕООД|22.02|1|4|0|C|| L01CD01|Paclitaxel|LH035|PACLITAXEL KABI|concentrate for solution for infusion|6 mg/ml - 5 ml|mg|1|30|Фрезениус Каби България ЕООД|4.4|1|4|0|C|| L01CD01|Paclitaxel|LH034|"Paclitaxel ""Ebewe"""|concentrate for solution for infusion|6 mg/ml - 50 ml|mg|1|300|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|66.05|1|4|0|C|| L01CD01|Paclitaxel|LH031|"Paclitaxel ""Ebewe"""|concentrate for solution for infusion|6 mg/ml - 25 ml|mg|1|150|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|33.03|1|4|0|C|| L01CD01|Paclitaxel|LH030|"Paclitaxel ""Ebewe"""|concentrate for solution for infusion|6 mg/ml - 16,7 ml|mg|1|100.2|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|22.02|1|4|0|C|| L01CD01|Paclitaxel|LH029|"Paclitaxel ""Ebewe"""|concentrate for solution for infusion|6 mg/ml- 5 ml|mg|1|30|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|6.61|1|4|0|C|| L01CD01|Paclitaxel|LH028|Genexol 100 mg|sol.for inf.|100|mg|1|100|Нео Балканика ЕООД|22.02|1|4|0|C|| L01CD01|Paclitaxel|LH026|Genexol 30 mg|sol.for inf.|30|mg|1|30|Нео Балканика ЕООД|6.61|1|4|0|C|| L01CD01|Paclitaxel|LH017|Sindaxel|sol.for inf.|300|mg|1|300|Актавис ЕАД, България|66.05|1|4|0|C|| L01CD01|Paclitaxel|LH009|Sindaxel|sol.for inf.|30|mg|1|30|Актавис ЕАД, България|6.61|1|4|0|C|| L01CD01|Paclitaxel|LH012|Sindaxel|sol.for inf.|100|mg|1|100|Актавис ЕАД, България|22.02|1|4|0|C|| L01CD02|Docetaxel|LH049|DOCETAX|concentrate for sol. for inf.|40 mg/ml - 0,5 ml + solvent 1,5 ml|mg|1|20|Cipla Ltd, UK|8.31|1|4|0|C|| L01CD02|Docetaxel|LH051|DOCETAX|concentrate for solution for infusion|40 mg/ml - 2 ml + solvent 6 ml|mg|1|80|Cipla Ltd, UK|33.24|1|4|0|C|| L01CD02|Docetaxel|LH060|TAXOTERE|concentrate for sol. for inf.|80 mg/ 4 ml|mg|1|80|Aventis Pharma S.A, France|33.24|1|4|0|C|| L01CD02|Docetaxel|LH063|DOCETAXEL HOSPIRA|concentrate for sol. for inf.|10 mg/ ml - 8 ml|mg|1|80|Hospira UK Limited, UK|33.24|1|4|0|C|| L01CD02|Docetaxel|LH064|DOCETAXEL HOSPIRA|concentrate for sol. for inf.|10 mg/ ml - 2 ml|mg|1|20|Hospira UK Limited, UK|8.31|1|4|0|C|| L01CD02|Docetaxel|LH331|Tolnexa|concentrate for sol. for inf.|20 mg/ml - 8 ml|mg|1|160|KRKA, d.d.|66.47|1|4|0|C|| L01CD02|Docetaxel|LH059|TAXOTERE|concentrate for sol. for inf.|20 mg/1 ml|mg|1|20|Aventis Pharma S.A, Франция|8.31|1|4|0|C|| L01CD02|Docetaxel|LH231|Docetaxel Accord|concentrate for sol. for inf.|160 mg/8 ml|mg|1|160|Аccord Healthcare Limited, UK|66.47|1|4|0|C|| L01CD02|Docetaxel|LH230|Docetaxel Accord|concentrate for sol. for inf.|80 mg/4 ml|mg|1|80|Accord Healthcare Ltd, UK|33.24|1|4|0|C|| L01CD02|Docetaxel|LH319|Tolnexa|concentrate for sol. for inf.|20 mg/ml - 4 ml|mg|1|80|KRKA, d. d.|33.24|1|4|0|C|| L01CD02|Docetaxel|LH318|Tolnexa|concentrate for sol. for inf.|20 mg/ml - 1 ml|mg|1|20|KRKA, d. d.|8.31|1|4|0|C|| L01CD02|Docetaxel|LH236|Docetaxel Kabi| concentrate for sol. for inf.|80 mg/4 ml|mg|1|80|Fresenius Kabi Oncology Plc, UK|33.24|1|4|0|C|| L01CD02|Docetaxel|LH223|DOCETAXEL ACTAVIS| concentrate for sol. for inf.|20 mg/1 ml|mg|1|20|Actavis Group PTC ehf, Исландия|8.31|1|4|0|C|| L01CD02|Docetaxel|LH224|DOCETAXEL ACTAVIS| concentrate for sol. for inf.|80 mg/4 ml|mg|1|80|Actavis Group PTC ehf, Исландия|33.24|1|4|0|C|| L01CD02|Docetaxel|LH225|DOCETAXEL HOSPIRA|concentrate for sol. for inf.|10 mg/ ml - 16 ml|mg|1|160|Hospira UK Limited, UK|66.47|1|4|0|C|| L01CD02|Docetaxel|LH229|Docetaxel Accord|concentrate for sol. for inf.|20 mg/1 ml|mg|1|20|Accord Healthcare Ltd, UK|8.31|1|4|0|C|| L01CD04|Cabazitaxel|LH274|Jevtana|concentrate and solvent for solution for infusion|60|mg|1|60|Sanofi Aventis Groupe, Франция|8742.05|1|4|0|C|| L01CX01|Trabectedin|LH069|YONDELIS|powder for concentrate for solution for infusion|1|mg|1|1|Pharma Mar S.A, Испания|3891.32|1|4|0|C|| L01CX01|Trabectedin|LH071|YONDELIS|powder for concentrate for solution for infusion|0.25|mg|1|0.25|Pharma Mar S.A, Испания|972.83|1|4|0|C|| L01DB01|Doxorubicin|LH275|Doxorubicin Accord|concentrate for solution for infusion|2 mg/ml-25 ml|mg|1|50|Accord Healthcare Limited Обединено кралство|34.07|1|3|0|C|| L01DB01|Doxorubicin hydrochloride|LH281|Myocet|powder, dispersion and concentrate for dispersion for infusion|50|mg|2|100|Teva Pharma B.V., Холандия|2062.01|1|2|0|C|| L01DB03|Epirubicin|LH076|Episindan|powder for sol. for inj.|50|mg|1|50|Актавис ЕАД България|43.33|1|4|0|C|| L01DB03|Epirubicin hydrochloride|LH027|Ecclepia|solution for injection|2 mg/ml - 5 ml|mg|1|10|Ромастру Трейдинг ЕООД, България|8.67|1|4|0|C|| L01DB03|Epirubicin hydrochloride|LH038|Ecclepia|solution for injection|2 mg/ml - 25 ml|mg|1|50|Ромастру Трейдинг ЕООД, България|43.33|1|4|0|C|| L01DB03|Epirubicin hydrochloride|LH040|Ecclepia|solution for injection|2 mg/ml - 50 ml|mg|1|100|Ромастру Трейдинг ЕООД, България|86.66|1|4|0|C|| L01DB03|Epirubicin|LH024|EPISINDAN|solution for infusion|2 mg/ml - 50 ml|mg|1|100|Actavis Group PTC ehf, Исландия|86.66|1|4|0|C|| L01DB03|Epirubicin|LH019|EPIRUBICIN EBEWE|concentrate for solution for injection/ infusion|2 mg/ml- 50 ml|mg|1|100|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|86.66|1|4|0|C|| L01DB03|Epirubicin|LH015|"EPIRUBICIN ""EBEWE"""|concentrate for solution for injection/ infusion|2 mg/ml- 25 ml|mg|1|50|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|43.33|1|4|0|C|| L01DB03|Epirubicin|LH014|EPIRUBICIN EBEWE|concentrate for sol. for inj./inf.|2 mg/ml- 5 ml|mg|1|10|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|8.67|1|4|0|C|| L01DB03|Epirubicin|LH004|Farmorubicin PFS|sol. for inj.|50|mg|1|50|Pfizer Enterprises SARL, Luxembourg|43.33|1|4|0|C|| L01DB03|Epirubicin|LH003|Farmorubicin PFS|sol. for inj.|10|mg|1|10|Pfizer Enterprises SARL, Luxembourg|8.67|1|4|0|C|| L01DB03|Epirubicin hydrochloride|LH332|Episindan|sol. for inj.|2 mg/ml - 25 ml|mg|1|50|Actavis Group PTC ehf|43.33|1|4|0|C|| L01DB06|Idarubicin|LH047|ZAVEDOS|powder for sol. for inf.|5 mg|mg|1|5|Pfizer Enterprises SARL, Luxembourg|58.54|1|4|0|C|| L01DB06|Idarubicin|LH065|ZAVEDOS|powder for sol. for inf.|10 mg|mg|1|10|Pfizer Enterprises SARL, Luxembourg|117.08|1|4|0|C|| L01DB06|Idarubicin|LH044|ZAVEDOS|capsules|10 mg|mg|1|10|Pfizer Enterprises SARL, Luxembourg|94.49|4|0|0|C|3| L01DB06|Idarubicin|LH042|ZAVEDOS|capsules|5 mg|mg|1|5|Pfizer Enterprises SARL, Luxembourg|47.25|4|0|0|C|3| L01DB07|Mitoxantrone|LH242|ONCOTRONE|solution for injection or infusion|2 mg/ml - 10 ml|mg|1|20|Baxter Oncology GmbH, Germany|62.51|1|4|0|C|| L01DB07|Mitoxantrone|LH075|MITOXANTRON EBEWE|concentrate for solution for infusion|2 mg/ml - 10 ml|mg|1|20|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|62.51|1|4|0|C|| L01DC03|Mitomycin|LH097|Mitomycin-C Kyowa|powd. Inj.|20|mg|1|20|KYOWA HAKKO KIRIN UK|53.38|1|4|0|C|| L01XA01|Cisplatin|LH100|Sinplatin|concentrate for solution for infusion|50|mg|1|50|Актавис ЕАД, България|10.72|1|4|0|C|| L01XA01|Cisplatin|LH102|"CISPLATIN ""EBEWE"" "|concentrate for solution for infusion|1 mg/ml - 100 ml|mg|1|100|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|21.44|1|4|0|C|| L01XA01|Cisplatin|LH104|"CISPLATIN ""EBEWE"" "|concentrate for solution for infusion|0,5 mg/ml - 20 ml|mg|1|10|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|2.14|1|4|0|C|| L01XA01|Cisplatin|LH106|"CISPLATIN ""EBEWE"" "|concentrate for solution for infusion|0,5 mg/ml - 50 ml|mg|1|25|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|5.36|1|4|0|C|| L01XA01|Cisplatin|LH107|"CISPLATIN ""EBEWE"" "|concentrate for solution for infusion|0,5 mg/ml - 100 ml|mg|1|50|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|10.72|1|4|0|C|| L01XA01|Cisplatin|LH232|Cisplatin Accord|concentrate for solution for infusion|1 mg/ml - 100 ml|mg|1|100|Accord Healthcare Limited, UK|21.44|1|4|0|C|| L01XA01|Cisplatin|LH109|Cisplatin Accord|concentrate for solution for infusion|1 mg/ml - 50 ml|mg|1|50|Accord Healthcare Limited, UK|10.72|1|4|0|C|| L01XA02|Carboplatin|LH110|Carboplatin - Teva|solution for infusion|10 mg/ ml-15 ml|mg|1|150|Тева Фармасютикълс България ЕООД ул. Н.В. Гогол 15, ет. 1, 1124 София, България|22.14|1|4|0|C|| L01XA02|Carboplatin|LH127|Carboplatin Actavis|concentrate for solution for infusion|10 mg/ml - 15 ml|mg|1|150|Actavis Group PTC ehf, Исландия|22.14|1|4|0|C|| L01XA03|Oxaliplatin|LH265|Oxaliplatin Aq Vida|concentrate for solution for infusion|5 mg/ml - 10 ml|mg|1|50|AqVida GmbH Германия|15.73|1|4|0|C|| L01XA03|Oxaliplatin|LH266|Oxaliplatin Aq Vida|concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|AqVida GmbH Германия|31.46|1|4|0|C|| L01XA03|Oxaliplatin|LH267|Oxaliplatin Aq Vida|concentrate for solution for infusion|5 mg/ml - 40 ml|mg|1|200|AqVida GmbH Германия|62.92|1|4|0|C|| L01XA03|Oxaliplatin|LH132|Eloxatin|concentrate for solution for infusion|100|mg|1|100|Санофи-Авентис България ЕООД|31.46|1|4|0|C|| L01XA03|Oxaliplatin|LH135|Eloxatin|concentrate for solution for infusion|50|mg|1|50|Санофи-Авентис България ЕООД|15.73|1|4|0|C|| L01XA03|Oxaliplatin|LH143|OXALIPLATIN 'EBEWE'|powder for solution for infusion|5 mg/ml - 10 ml|mg|1|50|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|15.73|1|4|0|C|| L01XA03|Oxaliplatin|LH144|OXALIPLATIN 'EBEWE'|powder for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|31.46|1|4|0|C|| L01XA03|Oxaliplatin|LH145|OXALIPLATIN 'EBEWE'|powder for solution for infusion|5 mg/ml - 30 ml|mg|1|150|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|47.19|1|4|0|C|| L01XA03|Oxaliplatin|LH146|OXALIPLATIN ACCORD|powder for solution for infusion|5 mg/ml - 10 ml|mg|1|50|Accord Healthcare Limited, UK|15.73|1|4|0|C|| L01XA03|Oxaliplatin|LH148|OXALICIP|powder for solution for infusion|50|mg|1|50|МС ФАРМА АД|15.73|1|4|0|C|| L01XA03|Oxaliplatin|LH149|OXALICIP|powder for solution for infusion|100|mg|1|100|МС ФАРМА АД|31.46|1|4|0|C|| L01XA03|Oxaliplatin|LH237|OXALIPLATIN ACCORD|concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Аccord Healthcare Limited - Обединено кралство|31.46|1|4|0|C|| L01XA03|Oxaliplatin|LH261|Oxaliplatin Actavis|concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Actavis Group PTC ehf., Iceland|31.46|1|4|0|C|| L01XA03|Oxaliplatin|LH262|Oxaliplatin Actavis|powder for solution for infusion|5 mg/ml - 10 ml|mg|1|50|Actavis Group PTC ehf., Iceland|15.73|1|4|0|C|| L01XA03|Oxaliplatin|LH284|Oxaliplatin Accord|concentrate for solution for infusion|5 mg/ml-10 ml|mg|1|50|Accord Healthcare Limited, UK|15.73|1|4|0|C|| L01XA03|Oxaliplatin|LH227|Oxaliplatin-Tchaikapharma|powder for solution for infusion|100|mg|1|100|„Чайкафарма Висококачествените Лекарства“ АД”, гр.София|29.89|1|4|0|C|| L01XA03|Oxaliplatin|LH268|Oxaliplatin Kabi|concentrate for solution for infusion|5 mg/ml - 10 ml|mg|1|50|Fresenius Kabi Oncology Plc., United Kingdom|15.73|1|4|0|C|| L01XA03|Oxaliplatin|LH269|Oxaliplatin Kabi|concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Fresenius Kabi Oncology Plc., United Kingdom|31.46|1|4|0|C|| L01XC02|Rituximab|LH320|MabThera|sol. for inj.|1400mg/15 ml|mg|1|1400|Roche Registration Ltd, UK|3497.42|1|4|0|C|| L01XC02|Rituximab|LH155|MabThera|concentrate for sol. for inf.|500|mg/50ml|1|500|Roche Registration Ltd, UK|2456.14|1|4|0|C|| L01XC02|Rituximab|LH154|MabThera|concentrate for sol. for inf.|100|mg/10ml|2|200|Roche Registration Ltd, UK|982.46|1|4|0|C|| L01XC03|Trastuzumab|LH310|Herceptin|solution for injection|600 mg/5 ml|mg|1|600|Roche Registration Ltd, UK|3477.08|3|2|0|C|| L01XC03|Trastuzumab|LH156|Herceptin|powder for concentrate for solution for infusion|150|mg|1|150|Roche Registration LimitedUnited Kingdom|1148.58|1|4|0|C|| L01XC06|Cetuximab|LH160|ERBITUX|solution for infusion|5 mg/ml - 20 ml|mg|1|100|Merck KGaA, Германия|413.32|1|4|0|C|| L01XC07|Bevacizumab|LH163|Avastin|concentrate for solution for infusion|25 mg/ml-16 ml|mg|1|400|Roche Registration LimitedUnited Kingdom|2317.99|1|4|0|C|| L01XC07|Bevacizumab|LH161|Avastin|concentrate for solution for infusion|25 mg/ml-4 ml|mg|1|100|Roche Registration LimitedUnited Kingdom|579.5|1|4|0|C|| L01XC08|Panitumumab|LH165|Vectibix|concentrate for solution for infusion|100|mg|1|100|Amgen Europe B.V. Холандия|834.85|1|4|0|C|| L01XC11|Ipilimumab|LH304|Yervoy|concentrate for solution for infusion|5 mg/ml-10 ml|mg|1|50|Bristol-Myers Squibb Pharma EEIG, Великобритания|8217.49|1|4|0|C|| L01XC11|Ipilimumab|LH303|Yervoy|concentrate for solution for infusion|5mg/ml-40 ml|mg|1|200|Bristol-Myers Squibb Pharma EEIG, Великобритания|32869.94|1|4|0|C|| L01XC12|Brentuximab vedotin|LH334|Adcetris|powder for concentrate for sol. for inf.|50|mg|1|50|Takeda Pharma A/S, Дания|7296.54|1|2|0|C|| L01XC13|Pertuzumab|LH335|Perjeta|concentrate for solution for infusion|420|mg|1|420|Roche Registration Ltd, UK|6336.76|1|2|0|C|| L01XE01|Imatinib|LH333|Nibix|hard caps.|100|mg|120|12000|Софарма АД|950.8|4|0|0|C|3| L01XE01|Imatinib|LH325|Meaxin|film-coated tabl.|100|mg|60|6000|KRKA, d. d.|475.4|4|0|0|C|3| L01XE01|Imatinib|LH324|Meaxin|film-coated tabl.|100|mg|120|12000|KRKA, d. d.|950.8|4|0|0|C|3| L01XE01|Imatinib|LH311|Egitinid|hard capsules|100|mg|120|12000|EGIS Pharmaceuticals PLC, Hungary|950.8|4|0|0|C|3| L01XE01|Imatinib|LH323|Hronileucem| caps. hard|100|mg|120|12000|Чайкафарма Висококачествените Лекарства АД, България|946.05|4|0|0|C|3| L01XE01|Imatinib|LH286|Neoxell|film-coated tabl.|100|mg|120|12000|Ромастру Трейдинг ЕООД, България|950.8|4|0|0|C|3| L01XE01|Imatinib|LH285|Imatinib Accord|film-coated tablets|100|mg|120|12000|Accord Healthcare Limited, UK|950.8|4|0|0|C|3| L01XE01|Imatinib|LH282|Imatinib Actavis|hard capsules|100|mg|120|12000|Actavis Group PTC ehf. Iceland|950.8|4|0|0|C|3| L01XE01|Imatinib|LH278|Glivec|film-coated tabl.|100|mg|120|12000|Novartis Europharm Limited, UK|950.8|4|0|0|C|3| L01XE01|Imatinib|LH271|Imatinib Zentiva|film-coated tabl.|100|mg|120|12000|Zentiva k.s. Чешка Република|950.8|4|0|0|C|3| L01XE01|Imatinib|LH270|Imakrebin|film-coated tabl.|100|mg|120|12000|Alvogen IPCO, Люксембург|950.8|4|0|0|C|3| L01XE01|Imatinib|LH203|Glivec|film-coated tablets|100|mg|120|12000|Novartis Europharm Limited, UK|4931.63|4|0|0|C|3| L01XE02|Gefitinib|LH167|IRESSA|film. coated tabl.|250|mg|30|7500|AstraZeneca AB, Швеция|4405.06|4|0|0|C|3| L01XE03|Erlotinib|LH168|Tarceva|film-coated tabl.|100|mg|30|3000|Roche Registration Limited, UK|2639.97|4|0|0|C|3| L01XE03|Erlotinib|LH169|Tarceva|film-coated tabl.|150|mg|30|4500|Roche Registration Limited, UK|3959.95|4|0|0|C|3| L01XE04|Sunitinib|LH172|Sutent|hard caps.|12.5|mg|30|375|Pfizer Limited, UK|2425.98|4|0|0|C|3| L01XE04|Sunitinib|LH176|Sutent|hard capsules|25|mg|30|750|Pfizer Limited United Kingdom|4851.95|4|0|0|C|3| L01XE04|Sunitinib|LH177|Sutent|hard caps.|50|mg|30|1500|Pfizer Limited, UK|9703.9|4|0|0|C|3| L01XE05|Sorafenib|LH179|Nexavar|film coated tabl.|200|mg|112|22400|Bayer Pharma AG, Germany|7042.45|4|0|0|C|3| L01XE06|Dasatinib|LH181|Sprycel|film-coated tablets|50|mg|60|3000|Bristol-Myers Squibb Pharma EEIG, UK|7020.46|4|0|0|C|3| L01XE07|Lapatinib|LH137|TYVERB|film-coated tablets, bottle|250|mg|140|35000|Glaxo Group Ltd, UK|4272.43|4|0|0|C|3| L01XE07|Lapatinib|LH133|TYVERB|film-coated tablets, bottle|250|mg|84|21000|Glaxo Group Ltd, UK|2563.46|4|0|0|C|3| L01XE08|Nilotinib|LH140|Tasigna|hard capsules|150|mg|28|4200|Novartis Europharm Limited, UK|1269.69|4|0|0|C|3| L01XE08|Nilotinib|LH139|Tasigna|hard capsules|200|mg|28|5600|Novartis Europharm Limited, UK|1694.14|4|0|0|C|3| L01XE09|Temsirolimus|LH158|TORISEL|concentrate and solvent for solution for injection|25|mg|1|25|Wyeth Europa Ltd., Великобритания|1667.69|1|4|0|C|| L01XE10|Everolimus|LH162|Afinitor|tabl.|5|mg|30|150|Novartis Europharm Limited, UK|3517.73|4|0|0|C|3| L01XE10|Everolimus|LH164|Afinitor|tablets|10|mg|30|300|Novartis Europharm Limited, UK|7035.46|4|0|0|C|3| L01XE11|Pazopanib|LH170|VOTRIENT|film. coated tabl.|400|mg|60|24000|Glaxo Group Ltd, UK|5450.36|4|0|0|C|3| L01XE11|Pazopanib|LH166|VOTRIENT|film. coated tabl.|200|mg|30|6000|Glaxo Group Ltd., UK|1362.6|4|0|0|C|3| L01XE13|Afatinib|LH336|Giotrif|film-coated tablets|30|mg|28|840|Boehringer Ingelheim International GmbH, Germany|3167.81|4|0|0|C|3| L01XE13|Afatinib|LH337|Giotrif|film-coated tablets|40|mg|28|1120|Boehringer Ingelheim International GmbH, Germany|4223.74|4|0|0|C|3| L01XE15|Vemurafenib|LH305|ZELBORAF|film-coated tabl.|240|mg|56|13440|Roche Registration Limited, UK|3788.32|4|0|0|C|3| L01XE16|Crizotinib|LH338|Xalkori|hard capsules|250|mg|60|15000|Pfizer Ltd, UK|11178.07|4|0|0|C|3| L01XE17|Axitinib|LH339|Inlyta|film-coated tablets|5|mg|56|280|Pfizer Ltd, UK|7970.5|4|0|0|C|3| L01XX17|Topotecan|LH183|Topotecan Accord|powder for concentrate for solution for infusion|4 mg/ 5 ml|mg|1|4|Accord Healthcare Limited, UK|24.18|1|4|0|C|| L01XX17|Topotecan|LH178|Topotecan Teva|concentrate for solution for infusion|1 mg/ml - 4 ml|mg|1|4|Teva Pharma B.V., Холандия|24.18|1|4|0|C|| L01XX17|Topotecan|LH180|POTACTASOL|powder for concentrate for solution for infusion|4|mg|1|4|Actavis Group PTC ehf., Исландия|24.18|1|4|0|C|| L01XX17|Topotecan|LH184|Hycamtin|caps. hard|1|mg|10|10|SmiteKline Beecham plc, UK|712.44|4|0|0|C|3| L01XX17|Topotecan|LH175|Hycamtin|powd. for concentrate for sol. for inf.|4|mg|1|4|SmithKline Beecham PLC|24.18|1|4|0|C|| L01XX17|Topotecan|LH226|Topotecan Hospira|concentrate for solution for infusion|4mg/4ml|mg|5|20|Hospira UK Ltd, Обединеното кралство|120.9|1|4|0|C|| L01XX17|Topotecan|LH233|Topotecan Accord|concentrate for solution for infusion|1 mg/ml - 4 ml|mg|1|4|Accord Healthcare Limited, UK|24.18|1|4|0|C|| L01XX17|Topotecan|LH238|Topotecan Kabi|powder for concentrate for solution for infusion|4|mg|1|4|Fresenius Kabi Oncology Plc., UK|24.18|1|4|0|C|| L01XX19|Irinotecan|LH194|NEOTECAN|concentrate for solution for infusion|100|mg|1|100|МС Фарма АД|33.61|1|4|0|C|| L01XX19|Irinotecan|LH193|NEOTECAN|solution for injection|40|mg|1|40|МС Фарма АД|13.44|1|4|0|C|| L01XX19|Irinotecan|LH201|IRINOTECAN HOSPIRA|concentrate for solution for infusion|20 mg/ml - 5 ml|mg|1|100|Hospira UK Limited, Великобритания|33.61|1|4|0|C|| L01XX19|Irinotecan hydrochloride trihydrate|LH200|Irinto|concentrate for solution for infusion|20 mg/ml - 2 ml|mg|1|40|"Чайкафарма Висококачествените лекарства"" АД, гр. София 1172, бул. Г.М. Димитров 1"|31.93|1|4|0|C|| L01XX19|Irinotecan hydrochloride trihydrate|LH199|Irinto|concentrate for solution for infusion|20 mg/ml - 5 ml|mg|1|100|"Чайкафарма Висококачествените лекарства"" АД, гр. София 1172, бул. Г.М. Димитров 1"|31.93|1|4|0|C|| L01XX19|Irinotecan|LH196|Irinotekan Actavis|concentrate for solution for injection|100|mg|1|100|Актавис ЕАД, България|33.61|1|4|0|C|| L01XX19|Irinotecan|LH195|Irinotekan Actavis|concentrate for solution for injection|40|mg|1|40|Актавис ЕАД, България|13.44|1|4|0|C|| L01XX23|Mitotane|LH202|Lysodren|tabl.|500|mg|100|50000|Laboratorie HRA Pharma, France|1283.11|4|0|0|C|3| L01XX32|Bortezomib|LH204|Velcade|powder for solution for injection|3.5|mg|1|3.5|Janssen Cilag International N.V., Belgium|2022.18|1|4|0|C|| L01XX35|Anagrelide|LH321|THROMBOREDUCTIN|caps.|0.5|mg|100|50|AOP Orphan Pharmaceuticals AG, Austria|720.77|4|0|0|C|3| L01XX41|Eribulin|LH306|Halaven|solution for injection|0,44 mg/ml - 2 ml|mg|1|0.88|Eisai Europe Limited, UK|748.7|1|4|0|C|| L01XX44|Aflibercept|LH342|Zaltrap|concentrate for sol. for inf.|25 mg/ml - 4 ml|mg|1|100|Sanofi-Aventis Groupe, France|742.64|1|3|0|C|| L01XX44|Aflibercept|LH341|Zaltrap|concentrate for sol. for inf.|25 mg/ml - 8 ml|mg|1|200|Sanofi-Aventis Groupe, France|1485.28|1|3|0|C|| L02AB02|Medroxyprogesterone acetate|LH206|Farlutal Depot|suspention for injection|500|g|1|500|Pfizer Enterprises SARL, Luxembourg|5.35|2|1|0|C|| L02BB04|Enzalutamide|LH343|Xtandi|soft capsules|40|mg|112|4480|Astellas Pharma Europe B.V., Нидерландия|7006.24|4|0|0|C|3| L02BX03|Abiraterone acetate|LH277|Zytiga|tabl.|250|mg|120|30000|Janssen-Cilag International NV, Белгия|6852.6|4|0|0|C|3| L03AA02|Filgrastim|LH124|NIVESTIM|solution for injection/ infusion in pre-filled syringe|12 MU/ 0,2 ml|mg|5|0.6|Hospira UK Limited, UK|126.6|2|1|0|C|| L03AA02|Filgrastim|LH123|NIVESTIM|solution for injection/ infusion in pre-filled syringe|30 MIU/ 0,5 ml|mg|5|1.5|Hospira UK Limited, UK|316.49|2|1|0|C|| L03AA02|Filgrastim|LH208|NEUPOGEN SINGLEJECT 30 MIU|solution for injection in pre-filled syringe|0.3|mg|1|0.3|Amgen Europe B.V., The Netherlands|63.3|2|1|0|C|| L03AA02|Filgrastim|LH130|Zarzio|solution for injection or infusion in pre-filled syr.|48 MU/ 0,5 ml|mg|5|2.4|Sandoz GmbH, Austria|506.38|2|1|0|C|| L03AA02|Filgrastim|LH128|Zarzio|solution for injection or infusion in pre-filled syr.|30 MU/ 0,5 ml|mg|5|1.5|Sandoz GmbH, Austria|316.49|2|1|0|C|| L03AA02|Filgrastim|LH125|NIVESTIM|solution for injection/ infusion in pre-filled syringe|48 MU (480 mcg/ 0,5 ml)|mg|5|2.4|Hospira UK Limited, UK|506.38|2|1|0|C|| L03AA02|Filgrastim|LH120|Tevagrastim 30 MIU/0,5 ml solution for injection or infusion|solution for injection or infusion|0.3|mg|1|0.3|Teva Generics GmbH,, Germany|63.3|2|1|0|C|| L03AA10|Lenograstim|LH316|Granocyte| powd.and solv. for solution for inj.|33.6 MIU + 1 ml solv. (1 fl. = 263 mcg)|mg|5|1.315|Санофи-Авентис България ЕООД|525.9|2|1|0|C|| L03AA13|Pegfilgrastim|LH234|Neulasta Solution for injection pre-filled syringe with needle guard 10 mg/ ml|pre - filled syr.|6|mg|1|6|Amgen Europe B.V., The Netherlands|1716.58|2|1|0|C|| L03AA14|Lipegfilgrastim|LH344|Lonquex|solution for injection in pre-filled syringe|6mg/0,6ml|mg|1|6|UAB Sicor Biotech, Литва|1711.22|3|1|0|C|| L03AB04|Interferon alfa-2a|LH151|Roferon-A|solution for injection|3 MIU|MU|1|3|Рош България ЕООД|28.32|3|1|0|C|| L03AX03|Mycobacterium bovis BCG (Baccilus Calmette - Guerin)|LH185|CALGEVAX|powder for suspension|11.25|mg|10|112.5|Бул Био - НЦЗПБ, ЕООД|208.42|1|4|0|C|6| L03AX16|Plerixafor|LH218|Mozobil|solution for injection|20 mg/ml - 1,2 ml|mg|1|24|Genzyme Europe B.V., The Netherlands|11489.14|3|1|0|C|| L04AA06|Mycophenolic acid/Mycophenolate mofetil|LH315|CellCept|caps. hard|250|mg|100|25000|Roche Registration Ltd, UK|42.42|4|0|0|I|| L04AD01|Ciclosporin|LH253|Sandimmun Neoral|oral solution|5000|mg|1|5000|Novartis Pharma GmbH, Germany|170.94|4|0|0|C|3| L04AD01|Ciclosporin|LH244|Sandimmun Neoral|caps. soft|50|mg|50|2500|Novartis Pharma GmbH, Germany|78.72|4|0|0|C|3| L04AD01|Ciclosporin|LH243|Sandimmun Neoral|caps. soft|25|mg|50|1250|Novartis Pharma GmbH, Germany|39.36|4|0|0|C|3| L04AX01|Azathioprine|LH255|AZATHIOPRINE TEVA|tablets|50|mg|100|5000|Тева Фармасютикълс България ЕООД, София, България|31.92|4|0|0|C|3| L04AX03|Methotrexate|LH191|METHOTREXATE "EBEWE"|tablets|2.5|mg|50|125|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|11.11|4|0|0|C|3| L04AX03|Methotrexate|LH192|METHOTREXATE "EBEWE"|tablets|5|mg|50|250|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|22.22|4|0|0|C|3| L04AX03|Methotrexate|LH322|METHOTREXATE "EBEWE"|sol. for inj.|10 mg/ml - 5 ml|mg|5|250|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|14.81|1|4|0|C|| L04AX03|Methotrexate|LH187|"METHOTREXATE ""EBEWE"""|concentrate for solution for infusion|100 mg/ml - 10 ml|mg|1|1000|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|36.96|1|4|0|C|| L04XX40|Ciclosporin|LH314|Sandimmun Neoral|oral. solution|5000|mg|1|5000|Novartis Pharma GmbH, Germany|170.94|4|0|0|I|| L04XX40|Ciclosporin|LH313|Sandimmun Neoral|caps. soft|25|mg|50|1250|Novartis Pharma GmbH, Germany|39.36|4|0|0|I|| L04XX40|Ciclosporin|LH312|Sandimmun Neoral|caps. soft|50|mg|50|2500|Novartis Pharma GmbH, Germany|78.72|4|0|0|I|| M05BA03|Pamidronic acid|MH008|PAMITOR|concentrate for sol. for inf.|15 mg/ ml - 6 ml|mg|1|90|Чайкафарма Висококачествените лекарства|257.12|1|4|0|C|| M05BA06|Ibandronic acid|MH004|IBANDRONIC ACID SANDOZ|cincentrate for solution for infusion|6 mg/6 ml|mg|5|30|Sandoz d.d., Slovenia|139.9|1|4|0|C|| M05BA06|Ibandronic acid|MH001|Bondronat|concentrate for solution for infusion|6|mg|1|6|Roche Registration Ltd, UK|27.98|1|4|0|C|| M05BA06|Ibandronic acid|MH005|IASIBON|concentrate for solution for infusion|6 mg/6 ml|mg|1|6|Pharmathen S.A., Greece|27.98|1|4|0|C|| M05BA06|Ibandronic acid|MH006|IASIBON|film tablets|50|mg|28|1400|Pharmathen S.A., Greece|82.38|4|0|0|C|3| M05BA06|Ibandronic acid|MH002|Bondronat|film-coated tablet|50|mg|28|1400|Roche Registration Ltd, UK|199.44|4|0|0|C|3| M05BA06|Ibandronic acid|MH014|Ibandronic acid Accord|concentrate for solution for infusion|6 mg/6 ml|mg|1|6|Accord Healthcare Ltd, UK|27.98|1|4|0|C|| M05BA06|Ibandronic acid|MH009|Ibandronic Acid Actavis|film-coated tablets|50|mg|28|1400|Actavis Group PTC ehf., Iceland|199.44|4|0|0|C|3| M05BA08|Zoledronic acid|MH003|Zometa|powder and solvent for solution for injection|4|mg|1|4|Novartis Europharm Ltd|22.91|1|4|0|C|| M05BA08|Zoledronic acid|MH019|Zoledronic acid Sandoz|concentrate for solution for infusion|4mg/5ml|mg|1|4|Sandoz d.d, Словения|22.91|1|4|0|C|| M05BA08|Zoledronic acid|MH018|ZYOLIX|concentrate for solution for infusion|4mg/5ml|mg|1|4|Ромастру Трейдинг ЕООД|22.91|1|4|0|C|| M05BA08|Zoledronic acid|MH016|Zoledronic acid Hospira|concentrate for solution for infusion|4mg/5ml|mg|1|4|Hospira UK Ltd., UK|22.91|1|4|0|C|| M05BA08|Zoledronic acid|MH022|Zoledronic acid Accord|concentrate for sol. for inf.|4 mg/5 ml|mg|1|4|Accord Healthcare Ltd, UK|22.91|1|4|0|C|| M05BA08|Zoledronic acid|MH020|Desinobon|concentrate for solution for infusion|4 mg/5 ml|mg|1|4|Alvogen IPCo.S.ar.l, Люксембург|22.91|1|4|0|C|| M05BA08|Zoledronic acid|MH015|Zoledronic acid Fresenius Kabi|concentrate for solution for infusion|4mg/5ml|mg|1|4|Фрезениус Каби България ЕООД|22.91|1|4|0|C|| M05BA08|Zoledronic acid|MH013|Zoledronic acid Teva|concentrate for solution for infusion|4mg/5ml|mg|1|4|Teva Pharma B.V., The Netherlands|22.91|1|4|0|C|| M05BA08|Zoledronic acid|MH011|Zoledronic acid Zentiva|concentrate for solution for infusion|4mg/5ml|mg|1|4|Novartis Europharm Ltd, UK|22.91|1|4|0|C|| M05BA08|Zoledronic acid|MH012|Zoledronic acid Actavis|concentrate for solution for infusion|4mg/5ml|mg|1|4|Actavis Group PTC enf., Исландия|22.91|1|4|0|C|| M05BX04|Denosumab|MH017|Xgeva|solution for injection|120 mg/1.7ml|mg|1|120|Amgen Europe BV., The Netherlands|699.67|2|1|0|C|| M05BX04|Denosumab|MH024|Xgeva|sol. for inj.|120 mg/1.7ml|mg|1|120|Amgen Europe BV., The Netherlands|699.67|2|3|0|C|| N02AA01|Morphine|NO610|Doltard|prolong release tabl.|30|mg|100|3000|Takeda Pharma A/S, Denmark|21.37|4|0|1|C|| N02AA01|Morphine|NO597|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 10|sol. inj.|20|mg/ml-1ml|10|200|Софарма АД, Илиенско шосе 16, 1220 София, България|14.48|2|0|1|C|| N02AA01|Morphine|NO595|MORPHINE SOPHARMA sol. inj. 10 mg/ml - 1 ml x 10|sol. inj.|10|mg/ml-1ml|10|100|Софарма АД, Илиенско шосе 16, 1220 София, България|7.24|2|0|1|C|| N02AA01|Morphine|NO572|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 100|sol. inj.|20|mg/ml-1ml|100|2000|Софарма АД, Илиенско шосе 16, 1220 София, България|144.77|2|0|1|C|| N02AA01|Morphine|NO596|MORPHINE SOPHARMA sol. inj. 10 mg/ml - 1 ml x 100|sol. inj.|10|mg/ml-1ml|100|1000|Софарма АД, Илиенско шосе 16, 1220 София, България|72.39|2|0|1|C|| N02AA01|Morphine|NO602|MST CONTINUS|modified-release tablets|30|mg|50|1500|Mundipharma Ges.m.b.H, Austria|10.69|4|0|1|C|| N02AA05|Oxycodone hydrochloride|NO618|Oxylan|prolonged- release tablets|40|mg|50|2000|G.L.Pharma GmbH., Австрия|96.28|4|0|1|C|| N02AA05|Oxycodone hydrochloride|NO617|Oxylan|prolonged- release tablets|20|mg|50|1000|G.L.Pharma GmbH., Австрия|48.12|4|0|1|C|| N02AA05|Oxycodone hydrochloride|NO619|Oxylan|prolonged- release tablets|80|mg|50|4000|G.L.Pharma GmbH., Австрия|192.53|4|0|1|C|| N02AA05|Oxycodone|NO580|OXYCONTIN|modified-release tabl.|20|mg|50|1000|Mundipharma Ges.m.b.H, Austria|48.12|4|0|1|C|| N02AA05|Oxycodone|NO581|OXYCONTIN|modified-release tabl.|80|mg|50|4000|Mundipharma Ges.m.b.H, Austria|192.53|4|0|1|C|| N02AA05|Oxycodone|NO582|OXYCONTIN|modified-release tabl.|10|mg|50|500|Mundipharma Ges.m.b.H, Austria|24.08|4|0|1|C|| N02AA05|Oxycodone|NO583|OXYCONTIN|modified-release tabl.|40|mg|50|2000|Mundipharma Ges.m.b.H, Austria|96.28|4|0|1|C|| N02AA05|Oxycodone|NO600|Oxycodone Actavis|caps. hard|10|mg|50|500|Actavis Group PTC ehf, Iceland|24.08|4|0|1|C|| N02AA05|Oxycodone|NO601|Oxycodone Actavis|caps. hard|20|mg|50|1000|Actavis Group PTC ehf, Iceland|48.12|4|0|1|C|| N02AA05|Oxycodone hydrochloride|NO612|Oxycodone Actavis|prolonged-release tabl.|10|mg|50|500|Actavis Group PTC ehf., Исландия|24.08|4|0|1|C|| N02AA05|Oxycodone hydrochloride|NO613|Oxycodone Actavis|prolonged-release tabl.|20|mg|50|1000|Actavis Group PTC ehf., Исландия|48.12|4|0|1|C|| N02AA05|Oxycodone hydrochloride|NO614|Oxycodone Actavis|prolonged-release tabl.|40|mg|50|2000|Actavis Group PTC ehf., Исландия|96.28|4|0|1|C|| N02AA05|Oxycodone hydrochloride|NO615|Oxylan|prolonged- release tabl.|5|mg|50|250|G.L.Pharma GmbH., Австрия|12.02|4|0|1|C|| N02AA05|Oxycodone hydrochloride|NO616|Oxylan|prolonged- release tablets|10|mg|50|500|G.L.Pharma GmbH., Австрия|24.08|4|0|1|C|| N02AA08|Dihydrocodeine|NP414|DHC Continus|modified-release tablets|90|mg|50|4500|Mundipharma Ges.m.b.H., Vienna, Austria|29.44|4|0|1|C|| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO603|TARGIN|prolong. release tabl.|40mg/20mg| mg|100|6000|Mundipharma GmbH, Австрия|554.26|4|0|1|C|| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO586|TARGIN 20 mg/10 mg X 50|prolonged release tablets|20|mg|50|1000|Mundipharma GmbH, Австрия|138.54|4|0|1|C|| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO584|TARGIN 5 mg/2,5 mg X 50|prolonged release tablets|5|mg|50|250|Mundipharma GmbH, Австрия|34.61|4|0|1|C|| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO585|TARGIN 10 mg/5 mg X 50|prolonged release tablets|10|mg|50|500|Mundipharma GmbH, Австрия|69.32|4|0|1|C|| N02AB02|Pethidine hydrochloride|NO589|LYDOL sol.for inj. 50 mg/ml- 2 ml x 50|solution for injection|100|mg/2ml|50|5000|Софарма АД, Илиенско шосе 16, 1220 София, България|84|2|0|1|C|| N02AB02|Pethidine hydrochloride|NO588|LYDOL sol.for inj. 50 mg/ml- 2 ml x 10|solution for injection|100|mg/2ml|10|1000|Софарма АД, Илиенско шосе 16, 1220 София, България|16.8|2|0|1|C|| N02AB03|Fentanyl|NO590|Victanyl 75 micrograms/h transdermal patches x 5|transdermal patches|75|mcg/h|5|375|Actavis Group PTC ehf, Iceland|40.24|4|0|1|C|| N02AB03|Fentanyl|NO591|Victanyl 25 micrograms/h transdermal patches x 5|transdermal patches|25|mcg/h|5|125|Actavis Group PTC ehf, Iceland|13.41|4|0|1|C|| N02AB03|Fentanyl|NO592|Victanyl 50 micrograms/h transdermal patches x 5|transdermal patches|50|mcg/h|5|250|Actavis Group PTC ehf, Iceland|26.83|4|0|1|C|| N02AB03|Fentanyl|NO593|Victanyl 100 micrograms/h transdermal patches x 5|transdermal patches|100|mcg/h|5|500|Actavis Group PTC ehf, Iceland|53.65|4|0|1|C|| N02AE01|Buprenorphine|NO604|Buprenorphin Actavis|transdermal patch|35 mcg/h|mcg|5|175|Actavis Group PTC ehf, Iceland|41.4|4|0|1|C|| N02AE01|Buprenorphine|NO606|Buprenorphin Actavis|transdermal patch|70 mcg/h|mcg|5|350|Actavis Group PTC ehf, Iceland|82.8|4|0|1|C|| N02AE01|Buprenorphine|NO605|Buprenorphin Actavis|transdermal patch|52,5 mcg/h|mcg|5|261|Actavis Group PTC ehf, Iceland|62.1|4|0|1|C|| N02AX02|Tramadol|NO611|TRAMADOL STADA|sol. for inj.| 50 mg/ml - 2 ml|mg|5|500|Stada Arzenimittel AG|4.88|2|0|1|C|| N02AX02|Tramadol|NP419|TRAMADOL STADA|capsule|50|mg|30|1500|Stada Arzenimittel AG|4.28|4|0|1|C|| N02AX02|Tramadol|NP415|TRAMALGIN sol.for inj. 50 mg/ml-2 ml x10|sol.for inj.|100|mg/2ml-2ml|10|1000|Софарма АД|9.76|2|0|1|C|| N02AX02|Tramadol hydrochloride|NP420|TRAMALGIN|caps.|50|mg|20|1000|УНИФАРМ АД|2.85|4|0|1|C|| N07BC01|Buprenorphine (as buprenorphine hydrochloride)|NO608|Buprenorphine Actavis|Sublingual tabl.|8mg|mg|7|56|Actavis Group PTC ehf, Iceland|9.61|4|0|1|C|| N07BC01|Buprenorphine (as buprenorphine hydrochloride)|NO607|Buprenorphine Actavis|Sublingual tabl.|2mg|mg|7|14|Actavis Group PTC ehf, Iceland|2.4|4|0|1|C|| N07BC01|Buprenorphine (as buprenorphine hydrochloride)|NO609|Buprenorphine Actavis|Sublingual tabl.|0,4mg|mg|7|2.8|Actavis Group PTC ehf, Iceland|0.48|4|0|1|C|| V03AC01|Deferoxamine|VH009|Desferal|powder for solution for injection|500|mg|10|5000|Novartis Pharma GmbH, Germany|53.58|1|4|0|C|1| V03AC02|Deferiprone|VH010|Ferriprox|oral solution|100 mg/ml-500 ml|mg|1|50000|Apotex Europe B.V., The Netherlands|340.34|4|0|0|C|3| V03AC02|Deferiprone|VH008|Ferriprox|film-coated tabl.|500|mg|100|50000|Apotex Europe B.V., The Netherlands|312.7|4|0|0|C|3| V03AC03|Deferasirox|VH014|Exjade|disp.tabl.|250|mg|28|7000|Novartis Pharma GmbH, Германия|694.86|4|0|0|C|3| V03AF03|Calcium folinate|VH015|Bendafolin|sol. for inj.|10 mg/ml - 100 ml|mg|1|1000|Lyomark Pharma GmbH, Germany|123.2|1|0|0|C|0| V03AF03|Calcium folinate|VH016|Bendafolin|sol. for inj.|10 mg/ml - 50 ml|mg|1|500|Lyomark Pharma GmbH, Germany|61.6|1|0|0|C|0| V03AF03|Calcium folinate|VH004|"CALCIUMFOLINATE 'EBEWE"""|concentrate for solution for infusion|10 mg/ ml - 5 ml|mg|5|250|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|30.8|1|0|0|C|0| V03AF03|Calcium folinate|VH003|"CALCIUMFOLINATE 'EBEWE"""|concentrate for solution for infusion|10 mg/ ml - 3 ml|mg|5|150|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|18.48|1|0|0|C|0| V03AF03|Calcium folinate|VH002|"CALCIUMFOLINATE 'EBEWE"""|capsules|15 mg|mg|20|300|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|14.92|4|0|0|C|3| V03AF03|Calcium folinate|VH007|Calcium folinate actavis|solution for inj. vial|10 mg/ml - 3 ml|mg|1|30|Actavis Group PTC enf., Iceland|3.7|1|0|0|C|0| V03AF03|Calcium folinate|VH013|Calcium folinate Actavis|solution for inj.|10 mg/ml - 10 ml|mg|1|100|Actavis Group PTC enf., Iceland|12.32|1|0|0|C|0| М05ВА08|Zoledronic acid|MH023|Zolira|concentrate for solution for infusion|4mg/5ml|mg|1|4|Иновамед ООД, България|22.91|1|4|0|C||